Please Wait.....
Report
Cell Therapy Biomanufacturing: Global Markets
Market Research Report I 2024-08-01 I 112 Pages I BCC Research
Description
Report Scope:
This report discusses the key trends shaping the global cell therapy biomanufacturing market, exploring factors that drive or hinder growth while providing valuable insights for stakeholders and potential newcomers. It examines R&D investment, heightened competition, and emerging technologies steering market dynamics. Moreover, the report assesses how advancements, product launches, and governmental initiatives impact future market trajectories. It also scrutinizes corporate actions like mergers, acquisitions, and partnerships. Additionally, the report evaluates the efficacy of various strategies in light of evolving technologies, intensifying competition, and shifting consumer demands.
Report Includes:
- 17 data tables and 25 additional tables
- Analysis of the global markets for cell therapy biomanufacturing
- Analyses of global market trends, with market revenue data from 2022, estimates for 2023, forecasts for 2024 and projected CAGRs through 2029
- Estimates of the current market size and revenue prospects, along with a market share analysis by product type, application, end user and region
- Facts and figures pertaining to the market dynamics, technological advances, product launches, regulatory scenarios, and the expected impact of macroeconomic factors
- An analysis of patents and emerging technologies
- Overview of sustainability trends and ESG developments in the industry, with a focus on consumer attitudes, companies' ESG score rankings and their ESG practices
- An analysis of the industry structure, including companies' market shares, merger and acquisition activity, and venture funding
- Profiles of the leading companies, including Thermo Fisher Scientific Inc., Bristol-Myers Squibb Co., Lonza, Merck KGaA, andBioSenic SA
Executive Summary
Summary:
The cell therapy biomanufacturing global market was worth $8.6 billion in 2023. The market is anticipated to achieve a CAGR of 11.5%, resulting in a value of $16.7 billion by the end of 2029. The growth trajectory of the cell therapy biomanufacturing market is underpinned by a convergence of factors that collectively fuel its expansion and innovation. Foremost among these drivers is the escalating prevalence of chronic and degenerative diseases worldwide, accentuating the urgent need for novel therapeutic interventions. This demand is met by the remarkable strides in cell therapy technologies, marked by breakthroughs in cell engineering, gene editing, and manufacturing processes.
These advancements empower researchers and clinicians to effectively harness cells' regenerative and immunomodulatory properties, offering targeted and personalized treatment modalities for a spectrum of ailments.
Regulatory entities like the FDA and European Medicines Agency (EMA) have championed initiatives to streamline approval processes, catalyzing the development and commercialization of cell-based therapies. Initiatives like the FDA's Regenerative Medicine Advanced Therapy (RMAT) designation and the EMA's Priority Medicines (PRIME) scheme expedite the translation of promising therapies from bench to bedside, fostering a conducive regulatory environment that incentivizes investment and innovation. Indeed, robust investment and funding streams from diverse sources, including venture capital, pharmaceutical conglomerates, and governmental agencies, underscore the burgeoning interest
and confidence in the market's potential. This financial backing fuels research, development, and clinical trials, propelling the proliferation of novel cell therapy solutions.
The expanding applications of cell therapy across oncology, regenerative medicine, and immune disorders widen the market's scope, offering multifaceted avenues for growth and therapeutic advancement. Breakthroughs in induced pluripotent stem cell (iPSC) therapy, mesenchymal stem cell (MSC) therapy, and chimeric antigen receptor (CAR) T-cell therapy underscore the versatility and efficacy of cell-based treatments in addressing an array of medical needs. As the industry evolves, collaborative efforts and strategic partnerships between biopharmaceutical companies, academic institutions, research organizations, and contract manufacturing organizations (CMOs) are pivotal in accelerating innovation, knowledge exchange, and technology transfer. By pooling resources, expertise, and infrastructure, stakeholders harness synergies to navigate regulatory complexities, optimize manufacturing processes, and expedite commercialization timelines. In sum, the cell therapy biomanufacturing market is poised for robust expansion. It is propelled by a confluence of factors that collectively shape its growth trajectory, spur innovation, and pave the way for transformative therapies that promise to improve patient outcomes and revolutionize healthcare standards.
Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Chapter 2 Market Overview
Overview
Cell Therapy
Stem Cell Transplantation
Stem Cell Biomanufacturing
Stem Cell Classification Based on Source
Stem Cell Classification Based on Ability to Differentiate
Uses of Stem Cells
Application of Stem Cells
Mechanism of Cell Therapy
Delivery Method of Cell-Based Therapy
Chapter 3 Market Dynamics
Overview
Market Drivers
Rising Prevalence of Chronic and Degenerative Diseases
Growing Investment in R&D
Technological Advancements in Bioprocessing
Expansion of Cell Therapy Manufacturing Infrastructure
Market Restraints
Complexity and Cost of Manufacturing
Supply Chain Issues
Product Stability and Shelf Life
Market Opportunities
Emerging Therapeutic Applications
Patient-Centric Healthcare Models
Chapter 4 Regulatory Structure
Regulatory Authorities
Regulatory Pathways
Quality Assurance
Manufacturing Standards
Global Harmonization Efforts
Chapter 5 Emerging Technologies and Developments
Newest Technologies/Key Developments
Advanced Cell Culture Systems
Genome Editing Technologies
Bioprocessing Innovation
Cell Sorting and Purification
Automation and Robotics
Data Analytics and Machine Learning
Tissue Engineering and Organoid Technologies
Point-of-Care Manufacturing
Chapter 6 Market Segmentation Analysis
Key Market Trends
Cell Therapy Biomanufacturing: Global Markets
Segmentation Breakdown
Market Analysis, by Product Type
Type of Therapy
Source of Cells
Market Analysis, by Application
Skeletal Muscle Repair
Bone Repair
Cancer
Cardiovascular Diseases
Neurological Disorders
Other Diseases
Geographic Breakdown
Market Analysis, by Region
North America
Europe
Asia-Pacific
Rest of the World
Chapter 7 Competitive Intelligence
Global Company Ranking
Strategic Analysis
M&A and Venture Funding
Chapter 8 Sustainability in Cell Therapy Biomanufacturing: An ESG Perspective
Environmental Impact
Supply Chain Sustainability
Social Responsibility
Corporate Governance
Product Lifecycle Management
Energy and Water
Recycling
Process Design and Materials
Recycling Single-Use Plastics
Work Environment
Chapter 9 Appendix
Methodology
Sources
Acronyms
Company Profiles
BIOSENIC
BRISTOL-MYERS SQUIBB CO.
DANAHER CORP.
IOVANCE BIOTHERAPEUTICS INC.
LISATA THERAPEUTICS
LONZA
MERCK KGAA
THERMO FISHER SCIENTIFIC INC.
List of Tables
Summary Table A : Global Market for Cell Therapy Biomanufacturing, by Product Type, Through 2029
Summary Table B : Global Market for Cell Therapy Biomanufacturing, by Application, Through 2029
Table 1 : Global Market for Cell Therapy Biomanufacturing, Through 2029
Table 2 : Global Market for Cell Therapy Biomanufacturing, by Product Type, Through 2029
Table 3 : Global Market for Cell Therapy Biomanufacturing, by Application, Through 2029
Table 4 : Global Market for Cell Therapy Biomanufacturing, by Region, Through 2029
Table 5 : North American Market for Cell Therapy Biomanufacturing, by Country, Through 2029
Table 6 : European Market for Cell Therapy Biomanufacturing, by Country, Through 2029
Table 7 : Asia-Pacific Market for Cell Therapy Biomanufacturing, by Country, Through 2029
Table 8 : RoW Market for Cell Therapy Biomanufacturing, by Country, Through 2029
Table 9 : Global Market Rankings of Cell Therapy Biomanufacturing, 2023
Table 10 : Report Sources
Table 11 : Acronyms Used in Cell Therapy Biomanufacturing Market
Table 12 : BioSenic: Company Snapshot
Table 13 : BioSenic: Financial Performance, 2022 and 2023
Table 14 : BioSenic: Product Portfolio
Table 15 : Bristol-Myers Squibb Co.: Company Snapshot
Table 16 : Bristol-Myers Squibb Co.: Financial Performance, FY 2022 and 2023
Table 17 : Bristol-Myers Squibb Co.: Product Portfolio
Table 18 : Bristol-Myers Squibb Co.: News/Key Developments, 2024
Table 19 : Danaher Corp.: Company Snapshot
Table 20 : Danaher Corp.: Financial Performance, FY 2022 and 2023
Table 21 : Danaher Corp.: Product Portfolio
Table 22 : Danaher Corp.: News/Key Developments, 2023
Table 23 : Iovance Biotherapeutics Inc.: Company Snapshot
Table 24 : Iovance Biotherapeutics Inc.: Financial Performance, FY 2022 and 2023
Table 25 : Iovance Biotherapeutics Inc: Product Portfolio
Table 26 : Iovance Biotherapeutics Inc.: News/Key Developments, 2023
Table 27 : Lisata Therapeutics: Company Snapshot
Table 28 : Lisata Therapeutics: Financial Performance, FY 2022 and 2023
Table 29 : Lisata Therapeutics: Product Portfolio
Table 30 : Lisata Therapeutics: News/Key Developments, 2022
Table 31 : Lonza: Company Snapshot
Table 32 : Lonza Financial Performance, FY 2022 and 2023
Table 33 : Lonza: Product Portfolio
Table 34 : Lonza: News/Key Developments, 2023
Table 35 : Merck KGaA: Company Snapshot
Table 36 : Merck KGaA: Financial Performance, FY 2022 and 2023
Table 37 : Merck KgaA: Product Portfolio
Table 38 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 39 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 40 : Thermo Fisher Scientific Inc: Product Portfolio
Table 41 : Thermo Fisher Scientific Inc: News/Key Developments, 2023
List of Figures
Summary Figure A : Global Market for Cell Therapy Biomanufacturing, by Product Type, 2021-2029
Summary Figure B : Global Market for Cell Therapy Biomanufacturing, by Application, 2021-2029
Figure 1 : Market Dynamics of Cell Therapy Biomanufacturing
Figure 2 : Global Market Shares of Cell Therapy Biomanufacturing, by Product Type, 2023
Figure 3 : Global Market Shares of Cell Therapy Biomanufacturing, by Application, 2023
Figure 4 : Global Market Shares of Cell Therapy Biomanufacturing, by Region, 2023
Figure 5 : North American Market Shares of Cell Therapy Biomanufacturing, by Country, 2023
Figure 6 : European Market Shares of Cell Therapy Biomanufacturing, by Country, 2023
Figure 7 : Asia-Pacific Market Shares of Cell Therapy Biomanufacturing, by Country, 2023
Figure 8 : RoW Market Shares of Cell Therapy Biomanufacturing, by Country, 2023
Figure 9 : Bristol-Myers Squibb Co.: Revenue Share, by Country/Region, FY 2023
Figure 10 : Danaher Corp.: Revenue Share, by Business Unit, FY 2023
Figure 11 : Danaher Corp.: Revenue Share, by Country/Region, FY 2023
Figure 12 : Lonza: Revenue Share, by Business Unit, FY 2023
Figure 13 : Lonza: Revenue Share, by Country/Region, FY 2023
Figure 14 : Merck KGaA: Revenue Share, by Business Unit, FY 2023
Figure 15 : Merck KgaA: Revenue Share, by Country/Region, FY 2023
Figure 16 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, 2023
Figure 17 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, 2023
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security